Skip to main content

Forteo News

FDA Approves Bonsity (teriparatide injection) to Treat Osteoporosis

SAN DIEGO, October 7, 2019 — Pfenex Inc. (NYSE American: PFNX) announced today that the U.S. Food and Drug Administration (FDA) has approved the new drug application (“NDA”) for Bonsity (PF708) submi...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Osteoporosis

Forteo patient information at Drugs.com